Bewersdorf, J. P., & Zeidan, A. M. (2021). Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML). Cancers (Basel).
Chicago Style CitationBewersdorf, Jan Philipp, i Amer M. Zeidan. "Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)." Cancers (Basel) 2021.
Cita MLABewersdorf, Jan Philipp, i Amer M. Zeidan. "Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)." Cancers (Basel) 2021.
Atenció: Aquestes cites poden no estar 100% correctes.